REACT-2 persistent symptom prevalences by BMI status

This is an additional cross-tabulated analysis of the data presented in Whitaker et al, <i>Persistent COVID-19 symptoms in a community study of 606,434 people in England (</i>https://doi.org/10.1038/s41467-022-29521-z).Presents unweighted prevalence of individual COVID-19 symptoms persisting for 12 weeks or more after symptom onset, stratified by BMI status. Both BMI and symptom status are self-reported.<b>BMI categories:</b>Underweight (BMI &lt;18.5 )Normal Weight (BMI 18.5 - 24.99)Overweight BMI - 25-29.99Obesity BMI ≥ 30 (n,%)<br><br><br><b>React-2 study protocol paper: </b>https://pubmed.ncbi.nlm.nih.gov/33997297/<b>Further information about the REACT-2 study:</b> https://www.imperial.ac.uk/medicine/research-and-impact/groups/react-study/studies/the-react-2-programme/